BioNTech SE Shares Outstanding 2019-2024 | BNTX

BioNTech SE shares outstanding for the quarter ending June 30, 2024 were 0.240B, a 0.24% decline year-over-year.

  • BioNTech SE 2023 shares outstanding were 0.243B, a 2.84% decline from 2022.
  • BioNTech SE 2022 shares outstanding were 0.25B, a 3.81% decline from 2021.
  • BioNTech SE 2021 shares outstanding were 0.26B, a 4.5% increase from 2020.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

BioNTech SE Shares Outstanding 2019-2024 | BNTX

  • BioNTech SE 2023 shares outstanding were 0.243B, a 2.84% decline from 2022.
  • BioNTech SE 2022 shares outstanding were 0.25B, a 3.81% decline from 2021.
  • BioNTech SE 2021 shares outstanding were 0.26B, a 4.5% increase from 2020.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Related Stocks
Company NameMarket
Cap
Amgen (AMGN)$178.8B
Regeneron Pharmaceuticals (REGN)$126.4B
Vertex Pharmaceuticals (VRTX)$124.2B
Gilead Sciences (GILD)$103.4B
Bristol Myers Squibb (BMY)$100.3B
CSL (CSLLY)$97.4B
GSK (GSK)$88.2B
Alnylam Pharmaceuticals (ALNY)$35.2B
Argenex SE (ARGX)$31.2B
Biogen (BIIB)$28.9B
Moderna (MRNA)$27.7B
Illumina (ILMN)$20.7B
BeiGene (BGNE)$19.2B
Genmab (GMAB)$17.5B
BioMarin Pharmaceutical (BMRN)$13.4B
Vaxcyte (PCVX)$13B
Incyte (INCY)$12.8B
Insmed (INSM)$12.6B
Exact Sciences (EXAS)$12.6B
Sarepta Therapeutics (SRPT)$12B
Bio-Techne Corp (TECH)$11.9B
QIAGEN (QGEN)$10.4B
Legend Biotech (LEGN)$9.3B
Bio-Rad Laboratories (BIO.B)$9.1B
Roivant Sciences (ROIV)$8.9B
Ascendis Pharma (ASND)$8.5B
Intra-Cellular Therapies (ITCI)$7.9B
Exelixis (EXEL)$7.9B
Halozyme Therapeutics (HALO)$7.8B
Repligen (RGEN)$7.6B